Oluwatobi Olojo

2023 – 2024

• Independently executed a complete experimental workflow investigating innate immune responses following viral infection of MRC-5 and CEF cell lines.
• Performed viral infection assays, monitored cytopathic effects, and supported viral handling under controlled laboratory conditions.
• Conducted RNA extraction, quantification, and reverse transcription for downstream gene expression studies.
• Ran RT-qPCR assays targeting innate immune markers (TNF, IFN-β, IRF3/7, NFKBIA, BIRC3).
• Performed PCR amplification and quality assessment using agarose gel electrophoresis.
• Conducted bioinformatic analysis using ShinyGO, TAC 4.0, and g:Profiler to interpret differential gene expression and pathway enrichment.
• Collaborated with multidisciplinary teams to design and implement innovative research projects.
• Maintained full GLP-compliant documentation, including experiment logs, deviations, and data files.

2023 – 2024

• Supported biochemistry and haematology assay workflows, ensuring accuracy of analyte quantification and analyser performance.
• Performed troubleshooting of Roche Cobas and Sysmex platforms, resolving QC failures, calibration drifts, and reagent instability.
• Maintained equipment calibration logs and ensured alignment with internal quality and GLP principles.
• Mentored junior staff in laboratory techniques and best practices to enhance team performance.
• Contributed to CAPA documentation, deviation reports, and audit readiness.

2021 – 2023

• Developed and validated laboratory protocols and SOPs, ensuring compliance with regulatory standards.
• Supported implementation of automated platforms and new LIMS modules, including user testing and workflow error analysis.
• Carried out analytical validation steps and result verification under quality-controlled conditions.

2019 – 2021

• Conducted daily analytical testing on haematology and coagulation platforms.
• Performed instrument verification for new diagnostic platforms and collaborated with technical reps during evaluations.
• Monitored KPIs, turnaround times, and test performance trends.